Vaccine Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 363

Table 13.1 Leading global vaccine and pharmaceutical corporations, 2010
Leading global vaccine corporations, 2010 Leading global pharmaceutical corporations, 2010

Global
sales a ($m)

Market
share (%)

Cumulative
market share (%)

Global sales b
($m)

Market
share (%)

Cumulative
market share (%) Rank Rank

1 GlaxoSmithKline 6,712 23 23 1 Pfi zer 55,602 7.0 7

2 Sanofi c 5,663 20 43 2 Novartis 46,806 5.9 13

3 Merck & Co. c 4,117 14 57 3 Merck & Co. 38,468 4.9 18

4 Pfi zer 3,667 13 70 4 Sanofi 35,875 4.5 22

5 Novartis 2,929 10 80 5 AstraZeneca 35,535 4.5 27

6 Others 5,743 20 20 6 GlaxoSmithKline 33,664 4.3

Global market 28,833 100 Global market 791,499 100.0

a Source : Sales of top fi ve companies based on GSK broker presentation, sales for “others” assume the top fi ve fi rms account for 80 % of the global vaccine
market (Kresse and Shah 2010 )
b Source : IMS Health, sales for audited markets only
c The sales of Sanofi Pasteur MSD are allocated 50/50 to Sanofi and Merck & Co.